Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 361621 - 361640 out of 563841 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lithuania (VVKT) | (L01FF03) durvalumab (adm: P) | IMFINZI 50 mg/ml koncentratas infuziniam tirpalui 10 ml N1 (AstraZeneca AB, Švedija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB,Švedija |
| Lithuania (VVKT) | (L01FF04) avelumab (adm: P) | Bavencio 20 mg/ml koncentratas infuziniam tirpalui 10 ml N1 (Merck Europe B.V., Nyderlandai) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckEuropeB.V.,Nyderlandai |
| Lithuania (VVKT) | (L01FF05) atezolizumab (adm: P) | Tecentriq 1200 mg koncentratas infuziniam tirpalui N1 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L01FF05) atezolizumab (adm: P) | Tecentriq 840 mg koncentratas infuziniam tirpalui 14 ml N1 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L01FF05) atezolizumab (adm: P) | Tecentriq 1875 mg injekcinis tirpalas 15 ml N1 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L01FF06) cemiplimab (adm: P) | LIBTAYO 350 mg koncentratas infuziniam tirpalui 7 ml N1 (Regeneron Ireland Designated Activity Company (DAC), Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronIrelandDesignatedActivityCompany[DAC],Airija |
| Lithuania (VVKT) | (L01FF07) dostarlimab | JEMPERLI 500 mg koncentratas infuziniam tirpalui 10 ml N1 (GlaxoSmithKline Trading Services Limited, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKlineTradingServicesLimited,Airija |
| Lithuania (VVKT) | (L01FF07) dostarlimab | JEMPERLI 500 mg koncentratas infuziniam tirpalui 10 ml N1 (GlaxoSmithKline Trading Services Limited, Airija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKlineTradingServicesLimited,Airija |
| Lithuania (VVKT) | (L01FX04) ipilimumab (adm: P) | YERVOY 5 mg/ml koncentratas infuziniam tirpalui 10 ml N1 (Bristol-Myers Squibb Pharma EEIG, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG,Airija |
| Lithuania (VVKT) | (L01FX05) brentuximab vedotin (adm: P) | Adcetris 50 mg milteliai infuzinio tirpalo koncentratui N1 (Takeda Pharma A/S, Danija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaA/S,Danija |
| Lithuania (VVKT) | (L01FX14) polatuzumab vedotin | Polivy 140 mg milteliai infuzinio tirpalo koncentratui N1 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L01FX14) polatuzumab vedotin | Polivy 30 mg milteliai infuzinio tirpalo koncentratui N1 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L01FX17) sacituzumab govitecan | Trodelvy 200 mg milteliai infuzinio tirpalo koncentratui N1 (Gilead Sciences Ireland UC, Airija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GileadSciencesIrelandUC,Airija |
| Lithuania (VVKT) | (L01FX24) teclistamab | TECVAYLI 10 mg/ml injekcinis tirpalas 3 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania (VVKT) | (L01FX24) teclistamab | TECVAYLI 90 mg/ml injekcinis tirpalas 1.7 ml N1 (Janssen-Cilag International N.V., Belgija) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V.,Belgija |
| Lithuania (VVKT) | (L01FX26) mirvetuximab soravtansine | ELAHERE 5 mg/ml koncentratas infuziniam tirpalui 20 ml N1 (AbbVie Deutschland GmbH & Co. KG , Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms | AbbVieDeutschlandGmbH&Co.KG,Vokietija |
| Lithuania (VVKT) | (L01FX28) glofitamab | Columvi 10 mg koncentratas infuziniam tirpalui 10 ml N1 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L01FX28) glofitamab | Columvi 2,5 mg koncentratas infuziniam tirpalui 2,5 ml N1 (Roche Registration GmbH, Vokietija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | RocheRegistrationGmbH,Vokietija |
| Lithuania (VVKT) | (L01FX32) elranatamab | ELREXFIO 40 mg/ml injekcinis tirpalas 1,1 ml N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerEuropeMAEEIG,Belgija |
| Lithuania (VVKT) | (L01FX32) elranatamab | ELREXFIO 40 mg/ml injekcinis tirpalas 1,9 ml N1 (Pfizer Europe MA EEIG, Belgija) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerEuropeMAEEIG,Belgija |
Pages
